AnnJi Pharmaceutical Co., Ltd.

NT$60.30As of Sun 8 Nov 2026, 12:00 UTC
TPEx:7754Healthcare
Country Taiwan
PE (Fwd) •••
TSR 2Y CAGR 16.45%
Div yield —
ROE (87.38%)
Biotechnology
Beta (5Y) (0.18)
PE TTM —
TSR TTM 31.70%
Mkt cap NT$6.087B
ROIC (48.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$63
5.18%
(25.90%)
Hold 2|4|3|2|3
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.71
0.72
0.72
0.70
34.62%
26.37%
22.91%
11.17%
RevenueNT$M
349.4
341.4
353.4
362.6
4.43%
0.19%
1.01%
6.71%
Peers (US$185.7M)
Cap (US$)
PE
192.3M
—
184.3M
5.939x
185.7M
5.250x
Capital
TTM
5Y
10Y
Leveragex
2.801
0.035
0.033
EBIT/Intx
7.691
0.413
0.368
Own earn%
313.54
46.10
41.88
Sh yield%
55.16
26.30
29.13
Owners
Insiders/Inst%
11.82
62.30
Short interest%
2.77
SBC / revenue%
3.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
16–21
$1 testx
—
Incr. ROIC%
8